SCHEMBL483814

SCHEMBL483814

CCCCCCCCCCC(C)C(C)(N)Cc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK1E P49674 1/20 0.50
SLC6A2 P23975 1/20 0.46
TAAR1 Q96RJ0 1/20 0.46
MMP1 P03956 2/20 0.39
MMP9 P14780 1/20 0.39
MMP13 P45452 1/20 0.39
CNR2 P34972 1/20 0.39
TRPA1 O75762 1/20 0.39
DNM1 Q05193 2/20 0.38
HTR2A P28223 1/20 0.38
MEN1 O00255 1/20 0.37
TP53 P04637 1/20 0.37
MAPK1 P28482 1/20 0.37
KMT2A Q03164 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
EPHX2 P34913 1/20 0.37
PKM P14618 1/20 0.37
CTSK P43235 1/20 0.37
ALDH1A1 P00352 1/20 0.37
MMP2 P08253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6056306 1.00 CSNK1E (0.50) CSNK1ESLC6A2TAAR1MMP1MMP9
Hydrochloric Acid SCHEMBL3294573 0.98 CSNK1E (0.49) CSNK1ESLC6A2TAAR1MMP1MMP9
Hydrochloric Acid SCHEMBL11799163 0.98 CSNK1E (0.49) CSNK1ESLC6A2TAAR1MMP1MMP9
Hydrochloric Acid SCHEMBL5053404 0.82 CSNK1E (0.55) CSNK1ESLC6A2TAAR1MMP1MMP9
Ammonia Solution, Strong SCHEMBL9326087 0.81 CSNK1E (0.50) CSNK1ESLC6A2TAAR1MMP1MMP9
Ammonia Solution, Strong SCHEMBL1782255 0.81 CSNK1E (0.50) CSNK1ESLC6A2TAAR1MMP1MMP9
SCHEMBL2788441 0.81 CSNK1E (0.47) CSNK1ESLC6A2TAAR1MMP1MMP9
Ammonia Solution, Strong SCHEMBL9800685 0.81 CSNK1E (0.50) CSNK1ESLC6A2TAAR1MMP1MMP9
Ammonia Solution, Strong SCHEMBL905580 0.81 CSNK1E (0.50) CSNK1ESLC6A2TAAR1MMP1MMP9
Ammonia Solution, Strong SCHEMBL875995 0.80 CSNK1E (0.46) CSNK1ESLC6A2TAAR1MMP1MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 164 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9644280-B2 Process for electrolytically depositing a tin- and ruthenium-based alloy, the electrolytic bath therefore and the alloy obtained therewith VALMET PLATING S.R.L. (IT) 2017-05-09 US claimed
US-20150354076-A1 Process for Electrolytically Depositing a Tin- and Rutenium-Based Alloy, the Electrolytic Bath That Permits Said Alloy to Deposit and the Alloy Obtained by Means of Said Process VALMET PLATING SRL (IT) 2015-12-10 US claimed
EP-2757180-B1 A process for electrolytically depositing a tin- and ruthenium-based alloy, the electrolytic bath that permits said alloy to deposit and the alloy obtained by means of said process VALMET PLATING S R L (IT) 2015-08-12 EP claimed
WO-2014111761-A1 A PROCESS FOR ELECTROLYTICALLY DEPOSITING A TIN- AND RUTHENIUM-BASED ALLOY, THE ELECTROLYTIC BATH THAT PERMITS SAID ALLOY TO DEPOSIT AND THE ALLOY OBTAINED BY MEANS OF SAID PROCESS VALMET S.P.A. (IT) 2014-07-24 WO claimed
EP-2757180-A1 A process for electrolytically depositing a tin- and ruthenium-based alloy, the electrolytic bath that permits said alloy to deposit and the alloy obtained by means of said process Valmet S.p.A. (IT) 2014-07-23 EP claimed
US-4229227-A MODIFIED MONTMORILLONITE, NITROCELLULOSE, AND A POLYETHER, OXIDE ADDUCT OR DICARBOXYLIC ESTER AND SOLVENTS SHISEIDO CO., LTD. (JP) 1980-10-21 US claimed
US-3950223-A WATER SOLUBLE AMINO SUGARS, AMINO ACIDS, AND CATIONIC SURFACTANTS AJINOMOTO CO., INC. (JA) 1976-04-13 US claimed
WO-2024179309-A1 USE OF ANNEXIN A5 IN HAIR GROWTH, HAIR NURTURING, HAIR CARE, HAIR LOSS PREVENTION, AND HAIR LOSS TREATMENT, AND RELATED PRODUCTS AND PHARMACEUTICAL COMPOSITIONS 上海萨丽斐生物科技有限公司 2024-09-06 WO disclosed
WO-2024007901-A1 METHOD FOR PREPARING OXYRESVERATROL 云南英格生物技术有限公司 2024-01-11 WO disclosed
WO-2023221544-A1 PREPARATION METHOD FOR AND USE OF INCLUSION OF RETINOL AND DERIVATIVE THEREOF 上海奥利实业有限公司 2023-11-23 WO disclosed
EP-3409703-B1 WATER ABSORBENT RESIN HAVING SILOXANE SKELETON, AND COSMETIC INCLUDING SAME SHINETSU CHEMICAL CO (JP) 2021-11-10 EP disclosed
EP-3527592-B1 (METH)ACRYLIC SILICONE GRAFT COPOLYMER AND A METHOD FOR PREPARING THE SAME SHINETSU CHEMICAL CO (JP) 2021-05-05 EP disclosed
US-10851194-B2 (meth)acrylic silicone graft copolymer and a method for preparing the same SHIN-ETSU CHEMICAL CO., LTD. (JP) 2020-12-01 US disclosed
EP-1001054-A2 Tin-copper alloy electroplating bath and plating process therewith C. UYEMURA & CO, LTD (JP) 2000-05-17 EP disclosed
EP-0202678-B1 PROCESS FOR DISSOLVING ENZYMES STABRA AG (CH) 1992-01-02 EP disclosed
US-4663288-A RESOLUBILIZATION OF A GLUCOSE ISOMERASE-AMINE COMPLEX USING CATION EXCHANGE RESIN NABISCO BRANDS, INC. (US) 1987-05-05 US disclosed
US-4634673-A COMPLEXING A GLUCOSE ISOMERASE EXTRACT WITH AN AMINE NABISCO BRANDS, INC. (US) 1987-01-06 US disclosed
US-4229227-A MODIFIED MONTMORILLONITE, NITROCELLULOSE, AND A POLYETHER, OXIDE ADDUCT OR DICARBOXYLIC ESTER AND SOLVENTS SHISEIDO CO., LTD. (JP) 1980-10-21 US disclosed
US-4222908-A MONTMORILLONITE, NITROCELLULOSE, POLYOXYALKYLENE GLYCOL SHISEIDO CO., LTD. (JP) 1980-09-16 US disclosed
US-3950223-A WATER SOLUBLE AMINO SUGARS, AMINO ACIDS, AND CATIONIC SURFACTANTS AJINOMOTO CO., INC. (JA) 1976-04-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10851194-B2 (meth)acrylic silicone graft copolymer and a method for preparing the same MSR1, ALG1, MTX2 CSNK1E 4081/4885SLC6A2 2461/4885TAAR1 986/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.